When a patient is diagnosed with a bacterial infection, medical staff need to identify the species attacking the body before it can be treated. The problem is, this process can take a few days and may ...

The market for HPAPIs is growing rapidly with the research industry's emphasis on oncology. On an industry level, how would you characterise the overall market for HPAPIs? The market is growing ...

A technique developed by Miami University associate professors of chemistry and biochemistry Dominik Konkolewicz and Rick Page may help enable more rapid and efficient development of new materials for ...

Lonza and Singzyme will use Singzyme’s enzymatic conjugation platform to develop novel bioconjugates. Lonza and Singzyme, a biotechnology company specializing in developing enzymes for protein ...

Lonza entered into two new collaborations with McSAF and Cristal Therapeutics to expand its bioconjugates offering. The collaborations are geared to enable the integration of two novel conjugation ...

Soon in virtually every hospital it will be possible to identify the bacterial species responsible for an infection developing in a patient in a matter of just a few minutes. A new, easy-to-adapt and ...

This panel will present a focused playbook for biopharma patent practitioners allowing them to protect the full scope of innovation reflected in the biologic development process. The discussion will ...

Since its recognition in the 1920s by Herman Staudinger, polymer science has had a tremendous impact on modern life, encompassing materials science, medicine and nanotechnology. Staudinger's work ...

Officials at Lonza say they will invest in additional bioconjugation capabilities in Visp, Switzerland. The expansion will add two multipurpose 1,200L manufacturing suites and manufacturing-related ...

SHANGHAI and SINGAPORE, July 1, 2025 /PRNewswire/ -- On June 30, WuXi XDC Cayman Inc. ("WuXi XDC", stock code: 2268.HK), a leading global Contract Research, Development and Manufacturing Organization ...

Now in its 12th year, Next Generation Protein Therapeutics Summit has continued to be the industry's most comprehensive conference for sharing new ideas to accelerate the discovery, engineering, and ...

These certificates cover all activities conducted in the site's Helix building, including its supporting warehouse and laboratory areas. The certificates were granted following the site's submission ...